Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP & Group Pres, Cardiology
-
Stock Symbol
-
BSX on NYSE
Joseph Michael Fitzgerald - trading volume in the past year for Boston Scientific Corp
Holdings reported by Joseph Michael Fitzgerald for Boston Scientific Corp
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
148K |
$13.2M |
$89.27 |
Nov 26, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
0 |
$634K |
$17.37 |
Oct 7, 2024 |
Direct |
Common Stock |
|
| Common Stock |
4.89K |
$437K |
$89.27 |
Nov 25, 2024 |
By Child |
|
|
| Restricted Stock Units |
4.17K |
$274K |
$65.82 |
Feb 17, 2024 |
Direct |
Common Stock |
|
| Deferred Stock Units |
0 |
$0 |
$65.82 |
Feb 18, 2024 |
Direct |
Common Stock |
|
| Performance Share Units |
0 |
|
$57.81 |
Jan 1, 2024 |
Direct |
Common Stock |
|
Transactions reported by Joseph Michael Fitzgerald for Boston Scientific Corp
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.